VEGFA and diabetic macular edema: The main limitation of our study was the small number of analyzed eyes to be able to draw a reliable conclusion regarding whether the additional application of 10 mg/0.1 mL of TA to the continuous administration of anti-VEGF therapy leads to a better therapeutic outcome of persistent diabetic macular edema in pseudophakic eyes.